MindPax MindPax

Digital Therapeutics and the Future of Mental Health Management

We are empowering patients and doctors to make better choices sooner.

The Digital Therapeutics Alliance defines digital therapeutics (DTx) as “evidence-based therapeutic interventions driven by high-quality software programs to prevent, manage, or treat a medical disorder or disease”.

The Common Traits of Digital Therapeutics

Data collection and Active Management

Digital Therapeutics collect disorder-specific health data, visualize them and actively support patients and doctors to manage these health conditions.

Mindpax: yes
Clinical Studies

Development of digital therapeutics applications must undergo rigorous clinical studies proving the effects on specific disorders and health conditions. This process includes thousands of hours of clinical observations, analysis and peer review of results.

Mindpax: yes
Supported by Medical Professionals

Given the high efficiency of these applications, and proof from clinical studies, the use of digital therapeutics apps is generally supported by medical professionals. Many digital therapeutics also follow the patient-doctor-carer co-management methodology.

Mindpax: yes
Covered by Insurance

Due to their proven efficiency and low risks, many health insurance companies are covering the cost of digital therapeutics software and hardware for their patients. In many cases, digital therapeutics have proven to be a great complement to conventional medicine.

Mindpax: In Progress
Controlled by Leading Health Authorities (i.e., FDA)

Digital therapeutics are tightly controlled by the FDA (Food and Drug Administration) in the US and similar organizations worldwide. This control ensures high efficiency and a very low risk of adverse effects.

Mindpax: In Progress

Successful Existing Digital Therapeutics Around the World

Digital therapeutics is not a music of the future. These are just some of the areas of medicine, where digital therapeutics have already been successfully implemented:
Diabetology(Diabetes Mellitus)
 
Neurology
(e.g., Parkinson’s Disease, Alzheimer’s disease, or the like)
Obesitology
 
 
 
Cardiology(e.g., hypertension, congestive heart failure, or the like)

Digital Therapeutics and Mental Disorders

When managing mental health disorders, patients often take conventional medication for long periods. While these medications have proven helpful, digital therapeutics can be a great supplement that helps patients, doctors and carers understand the symptoms of mental disorders more and therefore make better decisions faster.

Mindpax Is a Global Leader in Digital Therapeutics for Bipolar Disorder

We are the first company to combine microeducation, IPRST and CBT to help manage mental disorders.
We’re the first company in Germany to request DIGA approval for bipolar disorder digital therapeutics.
We’re a startup with the most extensive bipolar disease-specific behavioral data and digital and traditional biomarkers.
Learn more about mental health research

Science and Knowledge Hub

Validation Study
Validity of the Aktibipo Self-rating Questionnaire for the Digital Self-assessment of Mood and Relapse Detection in Patients With Bipolar Disorder
Feasibility Study
Classification of Actigraphy Records from Bipolar Disorder Patients Using Slope Entropy
Research Paper
Motor activity patterns can distinguish between interepisode bipolar disorder patients and healthy controls
contact-us-background

Contact Us

If you are interested in our vision and thinking about getting involved yourself, your loved one or investing in a meaningful project do not hesitate to contact us.

Contact Us
Infomail

Copyright © 2024 | Mindpax

Log in